Roy E. Smith

12.5k total citations · 6 hit papers
139 papers, 9.8k citations indexed

About

Roy E. Smith is a scholar working on Surgery, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Roy E. Smith has authored 139 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 36 papers in Oncology and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Roy E. Smith's work include Hormonal Regulation and Hypertension (26 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Platelet Disorders and Treatments (10 papers). Roy E. Smith is often cited by papers focused on Hormonal Regulation and Hypertension (26 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Platelet Disorders and Treatments (10 papers). Roy E. Smith collaborates with scholars based in United States, Australia and United Kingdom. Roy E. Smith's co-authors include John W. Funder, Zygmunt S. Krozowski, A. Ian Smith, P. Pearce, Stewart Anderson, Varuni Obeyesekere, Norman Wolmark, Anthony L. Albiston, Eleftherios P. Mamounas and D. Lawrence Wickerham and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Roy E. Smith

132 papers receiving 9.5k citations

Hit Papers

Mineralocorticoid Action: Target Tissue Specificity Is En... 1988 2026 2000 2013 1988 1991 2003 2006 1994 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
    1988 1.3k citations Roy E. Smith et al. profile →
  2. Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
    1991 1.1k citations Roy E. Smith et al. profile →
  3. The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
    2003 865 citations Stewart Anderson, Ann Brown et al. profile →
  4. Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
    2006 722 citations Stewart Anderson, Roy E. Smith et al. profile →
  5. Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
    1994 643 citations Anthony L. Albiston, Varuni Obeyesekere et al. Molecular and Cellular Endocrinology profile →
  6. Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
    2006 548 citations Roy E. Smith et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy E. Smith United States 39 3.6k 2.8k 2.8k 1.6k 1.5k 139 9.8k
Michael Torbenson United States 66 2.3k 0.6× 3.1k 1.1× 3.0k 1.1× 4.0k 2.5× 1.8k 1.2× 297 22.7k
Ann L. Oberg United States 62 2.8k 0.8× 1.7k 0.6× 1.2k 0.4× 1.7k 1.1× 878 0.6× 197 11.7k
Terry Hyslop United States 58 3.9k 1.1× 5.1k 1.8× 892 0.3× 2.0k 1.3× 1.3k 0.8× 291 13.2k
Geoffrey W. McCaughan Australia 73 4.7k 1.3× 1.2k 0.4× 1.4k 0.5× 5.2k 3.2× 940 0.6× 528 20.3k
Zachary Goodman United States 88 2.5k 0.7× 816 0.3× 2.9k 1.1× 4.5k 2.8× 1.9k 1.2× 299 42.1k
Anders Bergh Sweden 58 2.1k 0.6× 2.3k 0.8× 1.6k 0.6× 1.8k 1.1× 927 0.6× 345 12.4k
Alessandro Antonelli Italy 63 2.3k 0.6× 673 0.2× 5.5k 2.0× 1.3k 0.8× 2.2k 1.4× 351 13.4k
Paola Romagnani Italy 68 3.5k 1.0× 819 0.3× 982 0.4× 2.7k 1.7× 1.3k 0.8× 236 18.9k
Giuseppe Tonini Italy 62 8.8k 2.4× 2.3k 0.8× 813 0.3× 2.9k 1.8× 2.0k 1.3× 530 17.6k
Michael M. Lieber United States 72 2.8k 0.8× 2.0k 0.7× 1.9k 0.7× 3.5k 2.2× 965 0.6× 329 18.7k

Countries citing papers authored by Roy E. Smith

Since Specialization
Citations

This map shows the geographic impact of Roy E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy E. Smith more than expected).

Fields of papers citing papers by Roy E. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy E. Smith. The network helps show where Roy E. Smith may publish in the future.

Co-authorship network of co-authors of Roy E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Roy E. Smith. A scholar is included among the top collaborators of Roy E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy E. Smith. Roy E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Levy, Cynthia, Karl E. Anderson, Manisha Balwani, et al.. (2023). PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA. HemaSphere. 7(S3). e904346e–e904346e. 1 indexed citations
3.
Andrews, Miles C., Roy E. Smith, Mark Edinger, et al.. (2023). Design, optimisation and standardisation of a high‐dimensional spectral flow cytometry workflow assessing T‐cell immunophenotype in patients with melanoma. Clinical & Translational Immunology. 12(9). e1466–e1466. 3 indexed citations
4.
5.
Broome, Catherine M., Alexander Röth, David J. Kuter, et al.. (2020). Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia. Blood. 136(Supplement 1). 14–15. 12 indexed citations
6.
Malleshappa, Sudeep K Siddappa, Tapan Mehta, Smit Patel, et al.. (2020). Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncope. PLoS ONE. 15(4). e0230859–e0230859. 2 indexed citations
7.
Waibel, Kirk H., et al.. (2018). Outcomes of a military regional multispecialty synchronous telehealth platform and the importance of the dedicated patient presenter.. PubMed. 1–8. 6 indexed citations
8.
9.
10.
Sheth, Heena, et al.. (2014). Evaluation of Risk Factors for Rectus Sheath Hematoma. Clinical and Applied Thrombosis/Hemostasis. 22(3). 292–296. 51 indexed citations
11.
Fletcher, Jane, Jeremy Millar, Joanne Brooker, et al.. (2013). Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy. Psycho-Oncology. 22(10). 2169–2176. 48 indexed citations
12.
Parker, Ann M., Xinggang Liu, Anthony D. Harris, et al.. (2010). Respiratory Therapy Organization Changes Result in Increased Respiratory Care Resource Utilization in a Tertiary Care Medical Intensive Care Unit. CHEST Journal. 138(4). 766A–766A. 1 indexed citations
13.
Smith, Roy E., et al.. (2007). The limitations of distribution sampling for linkage learning. 364–369. 8 indexed citations
14.
Smith, Roy E., Stewart Anderson, Ann Brown, et al.. (2002). Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58. Clinical Breast Cancer. 3(5). 333–340. 20 indexed citations
15.
Smith, Roy E., et al.. (1999). Time-averaged mean velocity for volumetric blood flow measurements: an in vitro model validation study using physiological femoral artery flow waveforms. Ultrasound in Medicine & Biology. 25(4). 577–582. 4 indexed citations
16.
Smith, Roy E., et al.. (1998). Cloning and expression of a novel tissue specific 17β-hydroxysteroid dehydrogenase.. Endocrine Research. 24(3-4). 663–667. 30 indexed citations
17.
Smith, Roy E., et al.. (1997). Immunohistochemical and Molecular Characterization of the Rat 11β-Hydroxysteroid Dehydrogenase Type II Enzyme*. Endocrinology. 138(2). 540–547. 72 indexed citations
18.
Smith, Roy E., et al.. (1996). Rat 11β-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney. Molecular and Cellular Endocrinology. 120(1). 67–75. 42 indexed citations
19.
Smith, Roy E., Peter J. Little, Julie Maguire, Alicia Stein, & Zygmunt S. Krozowski. (1996). VASCULAR LOCALIZATION OF THE 11β‐HYDROXYSTEROID DEHYDROGENASE TYPE II ENZYME. Clinical and Experimental Pharmacology and Physiology. 23(6-7). 549–551. 30 indexed citations
20.
Krozowski, Zygmunt S., P. Provencher, Roy E. Smith, et al.. (1994). Isozymes of 11β-hydroxysteroid dehydrogenase: Which enzyme endows mineralocorticoid specificity?. Steroids. 59(2). 116–120. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Torbenson Breakdown of academic impact, for papers by Ann L. Oberg Breakdown of academic impact, for papers by Terry Hyslop Breakdown of academic impact, for papers by Geoffrey W. McCaughan Breakdown of academic impact, for papers by Zachary Goodman Breakdown of academic impact, for papers by Anders Bergh Breakdown of academic impact, for papers by Alessandro Antonelli Breakdown of academic impact, for papers by Paola Romagnani Breakdown of academic impact, for papers by Giuseppe Tonini Breakdown of academic impact, for papers by Michael M. Lieber
Rankless by CCL
2026